Determination of risk factors for cataract by aldose reductase genotype
A reductase and cataract technology, applied in the field of determining the risk rate of cataract through aldose reductase genotype, can solve the problem of low affinity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0049] Object and Diagnosis
[0050] The Diabetes Center of Prince of Wales Hospital in Hong Kong consecutively recruited 567 patients and diagnosed them according to World Health Organization standards (World Health Organization Technical Report Series (1985) 727). To increase the homogeneity of type 2 diabetes, those with diabetes diagnosed before age 35 and those with diabetes diagnosed for 3 years or less at the time of sample collection and who had been on insulin therapy were excluded. The presence of cataracts is indicated by direct ophthalmoscopy after pupil dilation, combined with best visual acuity sensitivity on Snellen's chart ≤ 20 / 70 in the same eye. Fundoscopy is performed by an ophthalmologist or a trained diabetes specialist.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com